Shaanxi Boson Biopharmaceutical Group

Shaanxi Boson Biopharmaceutical Group is a comprehensive pharmaceutical enterprise based in Xi'an, China, specializing in the research, development, and large-scale production of biochemical and synthetic peptide medicines. The company's product portfolio is primarily focused on critical care areas including cardiovascular and cerebrovascular diseases, hepatology, and immunology. Key marketed products include Alprostadil for injection, Glutathione for liver protection, and various thymic hormone preparations. Boson operates multiple GMP-certified production lines for injections, lyophilized powders, and solid dosages, positioning itself as a significant player in the Chinese domestic pharmaceutical market. The group integrates advanced extraction technologies with modern chemical synthesis to provide high-quality therapeutic solutions.